Typically, about 5 to 10% of the people using Wegovy have to stop because of serious side effects
Concerns and perspectives The studies so far do not report serious side effects related to GLP-1As use, however, in high doses they can lead to gastrointestinal problems, such as nausea, vomiting and diarrhea (Hall et al., 2015
Supplier quality varies dramatically across the compounded peptide space
For example, according to a study of over 41,000 adults with obesity, people taking tirzepatide: Were nearly twice as likely to lose at least 5% of their body weight than those taking semaglutide Were more than twice as likely to lose at least 10% of their body weight, and more than three times as likely to lose at least 15% of their body weight
Ozempic is not FDA-approved for weight loss, so Aetna typically wont cover it for that purpose
Contact Batash Endoscopic Weight Loss Center Today If you are exploring all your options including alternatives to Ozempic for weight loss, set up a consultation with Batash Endoscopic Weight Loss Center today